Literature DB >> 28681465

Symptom management in amyotrophic lateral sclerosis: We can do better.

Stephen A Goutman1, Zachary Simmons2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28681465      PMCID： PMC5749258          DOI： 10.1002/mus.25740

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  16 in total

1.  Psychological morbidity in ALS: the importance of psychological assessment beyond depression alone.

Authors:  Stephanie H Felgoise; Beatrice H Chakraborty; Elisabeth Bond; Jamie Rodriguez; Barbara A Bremer; Susan M Walsh; Eugene C Lai; Leo McCluskey; Zachary Simmons
Journal:  Amyotroph Lateral Scler       Date:  2010-08

2.  Multidisciplinary ALS care improves quality of life in patients with ALS.

Authors:  J P Van den Berg; S Kalmijn; E Lindeman; J H Veldink; M de Visser; M M Van der Graaff; J H J Wokke; L H Van den Berg
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

3.  Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.

Authors:  L Lacomblez; G Bensimon; P N Leigh; P Guillet; V Meininger
Journal:  Lancet       Date:  1996-05-25       Impact factor: 79.321

4.  Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients.

Authors:  Carlayne E Jackson; Gary Gronseth; Jeffrey Rosenfeld; Richard J Barohn; Richard Dubinsky; C Blake Simpson; April McVey; Pamela P Kittrell; Ruth King; Laura Herbelin
Journal:  Muscle Nerve       Date:  2009-02       Impact factor: 3.217

5.  Rehabilitation of motor neuron disease.

Authors:  Zachary Simmons
Journal:  Handb Clin Neurol       Date:  2013

6.  Prevalence of fatigue and depression in ALS patients and change over time.

Authors:  M C McElhiney; J G Rabkin; P H Gordon; R Goetz; H Mitsumoto
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-10       Impact factor: 10.154

7.  Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000.

Authors:  B J Traynor; M Alexander; B Corr; E Frost; O Hardiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

Review 8.  Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R G Miller; C E Jackson; E J Kasarskis; J D England; D Forshew; W Johnston; S Kalra; J S Katz; H Mitsumoto; J Rosenfeld; C Shoesmith; M J Strong; S C Woolley
Journal:  Neurology       Date:  2009-10-13       Impact factor: 9.910

Review 9.  Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R G Miller; C E Jackson; E J Kasarskis; J D England; D Forshew; W Johnston; S Kalra; J S Katz; H Mitsumoto; J Rosenfeld; C Shoesmith; M J Strong; S C Woolley
Journal:  Neurology       Date:  2009-10-13       Impact factor: 9.910

10.  Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study.

Authors:  Judith G Rabkin; Paul H Gordon; Martin McElhiney; Richard Rabkin; Sheena Chew; Hiroshi Mitsumoto
Journal:  Muscle Nerve       Date:  2009-03       Impact factor: 3.217
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.